ENDO Manufacturing Acquires Medivation Corp. to Expand Medical Device Portfolio

TOKYO, Jul 08 (Pulse News Wire) – Endo Manufacturing CO.,LTD. (7841.T) announced that its board of directors decided on July 08, 2026, to acquire shares of Medivation Corp.

And integrate it as a subsidiary. The move aligns with the company's three-year mid-term plan aimed at enhancing its operational portfolio through strategic investments. Medivation Corp., established in 2017, specializes in selling orthopedic implants, particularly the fracture treatment implant "Anklock anatomy plate," tailored to fit the bone structure of Japanese patients. By integrating Medivation Corp., Endo Manufacturing seeks to leverage synergies and strengthen its foothold in the medical device sector.

Key details of the acquisition include: - Capital: ¥4.5 million - Established: July 03, 2017 - Recent Financial Highlights (as of June 2025): - Total Assets: ¥453.6 million - Revenue: ¥930.7 million - Operating Profit: ¥113.8 million - Net Profit: ¥75.1 million The transaction is expected to close on July 13, 2026, making Medivation Corp. part of Endo Manufacturing’s consolidated group from the third quarter of 2026. Further impacts on the fiscal year ending December 2026 will be disclosed once assessed. This acquisition underscores Endo Manufacturing's commitment to expanding its medical device operations and improving capital efficiency within its broader strategic framework.